Company: CAAS
Filing Date: 2025-08-04
Form Type: 424B3
Source: 0001104659-25-073486
Chunk: 60

Company: China Automotive Systems, Inc.
Filing Date: 2025-08-04
Form: 424B3
Chunk 60
---
 with the authority
to warn, fine, and issue injunctions against PRC domestic companies, their controlling shareholders, and their advisors in connection
with a listing or offering securities, collectively, the “Subject Entities”, as well as individuals directly responsible
for these Subject Entities, the “Subject Individuals”. For failure to comply with the Trial Measures Negative List or the
Trial Measures Filing Obligations, or supply materially false or misleading statements in the filing and reporting required by the Trial
Measures, PRC domestic companies and their controlling shareholders, if the controlling shareholders induced the PRC domestic companies’
failure to comply, severally, may face warnings, injunctions to comply, and fines between RMB 1.0 million and RMB 10.0 million. The Subject
Individuals in these entities may severally, face warnings and fines between RMB 0.5 million and RMB 5.0 million. Advisors in listings
or offerings of securities that failed to dutifully advise the PRC domestic companies and their controlling shareholders in complying
with the Trial Measures and caused such failures to comply can face warnings and fines between RMB 0.5 million and RMB 5.0 million. The
Subject Individuals of these advisor entities may, severally, face warnings and fines between RMB 0.2 million and RMB 2.0 million.

Because our shares are already listed on Nasdaq,
we believe will be deemed as an “Existing Issuer” pursuant to the Trial Measures and, accordingly, are not required to complete
the filing procedures with the CSRC for our previous securities offerings. Nevertheless, in the event that we conduct any securities
issuance or offering in the future that would be captured by the Trial Measures, we will have to complete the filing procedures with
the CSRC within three (3) business days following the closing of such securities issuance or offering.

Therefore, in connection with our business operations
and the issuance or offering of securities to foreign investors, under currently effective PRC laws, regulations, and rules and
taking the Trial Measures into account, as of the date of this proxy statement/prospectus, we, our PRC subsidiaries, (i) are not
required to obtain permissions from or complete the filing procedures with the CSRC for our historical issuance or offering of securities
to foreign investors which has been completed before the date of implementation of the Trial Measures, but are required to go through
filing procedures with CSRC for our future